OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
Rohit Singhal, Lisa Aimee Hechanova
Current Cardiology Reports (2022) Vol. 24, Iss. 3, pp. 183-189
Closed Access | Times Cited: 8
Rohit Singhal, Lisa Aimee Hechanova
Current Cardiology Reports (2022) Vol. 24, Iss. 3, pp. 183-189
Closed Access | Times Cited: 8
Showing 8 citing articles:
Relation Between Serum Uric Acid to Albumin Ratio and Severity of Chronic Coronary Artery Disease
Damla Yalçınkaya, Kadir Karacali, Bilal Canberk Ilhan, et al.
Angiology (2023) Vol. 75, Iss. 4, pp. 386-393
Closed Access | Times Cited: 14
Damla Yalçınkaya, Kadir Karacali, Bilal Canberk Ilhan, et al.
Angiology (2023) Vol. 75, Iss. 4, pp. 386-393
Closed Access | Times Cited: 14
Effect of Hypoglycemic Drugs on Patients with Heart Failure with or without T2DM: A Bayesian Network Meta-analysis
Zhaolun Zhang, Su‐Hsun Liu, Jiawen Xian, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
Zhaolun Zhang, Su‐Hsun Liu, Jiawen Xian, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
NEW DIRECTIONS IN PHARMACOLOGICAL TREATMENT WITH SGLT-2 INHIBITOR MOLECULES IN THE LIGHT OF CURRENT GUIDELINES FOR DIABETES MELLITUS, HEART FAILURE AND KIDNEY DISEASE
Mariana Cornelia Tilinca
FARMACIA (2023) Vol. 71, Iss. 4, pp. 686-696
Open Access | Times Cited: 8
Mariana Cornelia Tilinca
FARMACIA (2023) Vol. 71, Iss. 4, pp. 686-696
Open Access | Times Cited: 8
Are serum uric acid levels predictors of cardiovascular risk? An update
Michael Georgoulis, Dimitri P. Mikhailidis, Demosthenes B. Panagiotakos
Current Opinion in Cardiology (2023) Vol. 38, Iss. 4, pp. 337-343
Closed Access | Times Cited: 6
Michael Georgoulis, Dimitri P. Mikhailidis, Demosthenes B. Panagiotakos
Current Opinion in Cardiology (2023) Vol. 38, Iss. 4, pp. 337-343
Closed Access | Times Cited: 6
Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population—an observational study from a tertiary care center in Karachi
Aisha Sheikh, Bhagwan Das, Saadia Sattar, et al.
Endocrine (2022) Vol. 80, Iss. 1, pp. 64-70
Open Access | Times Cited: 9
Aisha Sheikh, Bhagwan Das, Saadia Sattar, et al.
Endocrine (2022) Vol. 80, Iss. 1, pp. 64-70
Open Access | Times Cited: 9
Phytochemicals with sodium-glucose co-transporter inhibitory effects for the management of diabetes; a narrative review on recent findings
Mehrnaz Salehi, Najmeh Rayatpisheh, Mahsa Baghban Salehi, et al.
Journal of Renal Endocrinology (2023) Vol. 9, pp. e25095-e25095
Open Access | Times Cited: 1
Mehrnaz Salehi, Najmeh Rayatpisheh, Mahsa Baghban Salehi, et al.
Journal of Renal Endocrinology (2023) Vol. 9, pp. e25095-e25095
Open Access | Times Cited: 1
Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with Type 2 Diabetes Mellitus in Pakistani population -an observational study from a tertiary care center in Karachi
Aisha Sheikh, Bhagwan Das, Saadia Sattar, et al.
Research Square (Research Square) (2022)
Open Access
Aisha Sheikh, Bhagwan Das, Saadia Sattar, et al.
Research Square (Research Square) (2022)
Open Access
